| abstract |
A method for treating a medical condition, disease, or disorder mediated by a misfolded form of superoxide dismutase (SOD) in a subject in need of treatment. A method for treating a medical condition, disease or disorder mediated by a misfolded form of superoxide dismutase 1 (SOD1) in a subject in need of treatment, wherein the method is pharmaceutically acceptable. And (1) production of an exogenous antibody or fragment thereof that selectively binds to the misfolded form of SOD1, and / or (2) production of an endogenous antibody that selectively binds to the misfolded form of SOD1. A method comprising administering to a subject a composition comprising an inducing immunogen and / or a substance selected from (3) a nucleic acid sequence encoding (1) or (2). [Selection] Figure 1 |